- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04889911
Pilot RCT of Self-stigma Treatment for First Episode Psychosis (NECT-YA)
October 4, 2023 updated by: John Jay College of Criminal Justice, City University of New York
Development of a Stage-specific Adaptation of a Self-stigma Intervention for People Recovering From a First Episode of Psychosis
The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement.
The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The investigators will conduct a small RCT of the modified intervention (NECT-YA), combined with CSC, in comparison with CSC alone, with 40 persons recruited from three FEP programs, assessing acceptability and feasibility, and collecting data on primary outcome (service engagement and therapeutic alliance), related outcomes (self-esteem, hopelessness, and social functioning) and mechanisms of action (self-stigma, illness conceptions and coping).
The investigators will also collect qualitative data on participants' impressions of NECT-YA, which will inform additional revisions of the manual.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bethany Leonhardt, Psy.D.
- Phone Number: 317-880-8665
- Email: blleonha@iupui.edu
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Eskenazi Health, PARC Program
-
Contact:
- Bethany Leonhardt, Psy.D.
- Phone Number: 317-880-8665
- Email: Bethany.Leonhardt@eskenazihealth.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 24 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Meets criteria for FEP youth based on the following definition: age 15-24, onset of psychotic symptoms within the last 5 years, and an absence of a primary substance use or mood disorder that could be causing the psychotic symptoms (confirmed by program eligibility);
- Meets criteria for moderate (defined as a mean score of 1-1.5 on the 0-3 scale of the Internalized Stigma of Mental lllness Scale [ISMI]) or elevated (defined as a mean score of 1.5-3 on the 0-3 scale of the ISMI) self-stigma;
- Speaks English well enough to complete assessments and participate in groups;
- Is able to provide informed consent to participate.
Exclusion Criteria:
Does not meet any of the above inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care
NECT is a structured, 20-session group-based treatment called that combines psychoeducation, cognitive restructuring, and elements of narrative psychotherapy.
NECT-YA will be modified to meet the needs of people who have experienced an FEP and may have fewer sessions or be provided in individual format or via telehealth for this study.
NECT-YA will be offered to participants who are also receiving treatment within Coordinated Specialty Care programs for First Episode Psychosis.
|
Coordinated Specialty Care is an evidence-based, multimodal intervention for persons who have experienced a first episode of psychosis.
Other Names:
NECT is a psychosocial intervention focused on addressing the effects of self-stigma on individuals diagnosed with severe mental illnesses.
For the present study, the intervention has been modified to address the needs of youth who have recently experienced a first episode of psychosis.
Other Names:
|
Active Comparator: Coordinated Specialty Care
Coordinated Specialty Care is an evidence-based treatment for FEP that includes multiple treatment components.
The FEP programs in at the recruiting site follow the Coordinated Specialty Care model.
|
Coordinated Specialty Care is an evidence-based, multimodal intervention for persons who have experienced a first episode of psychosis.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Engagement
Time Frame: 0 minutes
|
Quantity of service use will be measured using attendance records for groups collected by facilitators, as well as administrative data on total service use within the FEP programs.
|
0 minutes
|
Working Alliance Inventory Short Form-Client Version
Time Frame: 2 minutes
|
A 12-item self-report measure of perception of relationship with the treatment team.
Higher scores indicate better working alliance.
|
2 minutes
|
Coping with Symptoms Checklist
Time Frame: 15 minutes
|
Assesses the use of problem-centered, neutral and avoidant coping strategies to deal with a variety of psychiatric symptoms commonly experienced by people with severe mental illnesses.
Higher scores in each subscale indicate more use of that type of coping strategy.
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Beck Hopelessness Scale
Time Frame: 3 minutes
|
The Beck Hopelessness Scale is a well-established 20-item scale that will be used to measure pessimistic expectations of the future.
Individual items are summed to provide an overall index of hope or its absence.
Higher scores indicate less hope.
|
3 minutes
|
Rosenberg Self Esteem Scale
Time Frame: 2 minutes
|
The Rosenberg Self Esteem Schedule will be used to measure self-esteem and self-deprecation.
Higher scores indicate more self-esteem.
|
2 minutes
|
Quality of Life Scale
Time Frame: 20 minutes
|
The Quality of Life Scale is a 21-item scale completed by clinically trained research staff following a semi-structured interview that assesses social functioning in multiple domains.
Higher scores indicate great social functioning.
|
20 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Internalized Stigma of Mental Illness Scale
Time Frame: 5 minutes
|
A 29 item measure of internalized stigma.
Higher scores indicate great internalized stigma.
|
5 minutes
|
Positive and Negative Syndrome Scale
Time Frame: 20 minutes
|
The Positive and Negative Syndrome Scale is a 30-item rating scale of psychiatric symptoms associated with psychosis, completed following a chart review and semi-structured interview.
Higher scores indicate more symptoms.
|
20 minutes
|
Recovery Style Questionnaire Recovery Style Questionnaire
Time Frame: 5 minutes
|
The Recovery Style Questionnaire is a 39 item self-report scale designed to assess the extent to which people with psychosis engage in "sealing over" versus "integration" with regard to how their self-conception.
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
February 23, 2018
First Submitted That Met QC Criteria
May 13, 2021
First Posted (Actual)
May 17, 2021
Study Record Updates
Last Update Posted (Actual)
October 6, 2023
Last Update Submitted That Met QC Criteria
October 4, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JJayCuny
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Youth
-
Charles Drew University of Medicine and ScienceLos Angeles County Department of Public HealthWithdrawnHealth Equity | Youth Participatory Action Research | Youth Mental Health
-
Midwest Evaluation & ResearchAvance Clinical Pty Ltd.Recruiting
-
Midwest Evaluation & ResearchImperial Valley Regional Occupational Program (IVROP)Active, not recruiting
-
Unity Health TorontoCovenant House Toronto; The Resource Association for Teens (RAFT); StepStones... and other collaboratorsActive, not recruiting
-
Murdoch Childrens Research InstituteRoyal Children's Hospital; RCH League of Former Trainees and Associates IncCompletedHomeless YouthAustralia
-
Centre for Addiction and Mental HealthCompletedHomelessness | YouthCanada
-
Unity Health TorontoCovenant House Toronto; Ontario Trillium Foundation; dk LeadershipCompleted
-
Lawson Health Research InstituteCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
citiesRISEAfrican Population and Health Research Center; Schizophrenia Research Foundation...Enrolling by invitationYouth Mental HealthIndia, Kenya
Clinical Trials on Coordinated Specialty Care
-
Indiana UniversityNational Institute of Mental Health (NIMH); Yale University; University of Michigan and other collaboratorsRecruitingSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Schizophreniform Disorders | Bipolar Disorder With Psychotic FeaturesUnited States
-
Northwell HealthNational Institute of Mental Health (NIMH)RecruitingFirst Episode PsychosisUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeCompletedLung Cancer | Advanced Cancer | Gastrointestinal CancerUnited States
-
University of North Carolina, Chapel HillIcahn School of Medicine at Mount Sinai; National Institute on Aging (NIA)Completed
-
University of MinnesotaUniversity of California, San FranciscoCompletedSchizophrenia | Schizoaffective Disorder | Psychosis | Psychosis NOS | Schizophreniform Disorders | Unspecified Psychosis | Bipolar Disorder With Psychotic Features | Depression Psychotic FeatureUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
MDRCKaiser Permanente; Robert Wood Johnson Foundation; Center for Health Care Strategies and other collaboratorsCompletedChronic Conditions Faced by Medicaid Recipients With DisabilitiesUnited States
-
University Hospital, AngersRecruiting
-
University of MiamiRecruitingDiabetes Mellitus, Type 1United States
-
University of MinnesotaNational Institute of Mental Health (NIMH)RecruitingSchizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Schizo Affective Disorder | Prodromal Schizophrenia | Major Depression With Psychotic Features | Schizophreniform Disorders | Unspecified Psychosis | Psychosis Nos/OtherUnited States